AQST vs DHI · rev $28.3M vs P/E 9.6, rev $34.25B
Aquestive Therapeutics Inc (AQST) versus DR Horton Inc (DHI) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
DR Horton Inc (DHI) is a residential construction company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
AQST currently screens at market cap $493.0M. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Not investment advice. Open the AQST and DHI stock pages for the full models.
Not investment advice.